We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”
Exploring the Future of Cell and Gene Therapies at Our HealthTech Leadership Dinner in Basel
We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.
A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.
Sébastien Stoitzner & Thibault Vercoutere Attend the Health Innovation Agency’s CAP Tour – Marseille
Swiss Biotech Day 2025
Heiko Bruhn, a key figure at GenSearch, will be attending the Swiss Biotech Day 2025 in Basel, one of Europe’s leading biotechnology conferences.
GenSearch Achieves Gold Rating on EcoVadis Sustainability Assessment
GenSearch is proud to announce its achievement of a Gold Rating from EcoVadis’ sustainability ratings platform. This rating has put GenSearch in the top five percent of companies assessed.
Read more “GenSearch Achieves Gold Rating on EcoVadis Sustainability Assessment”Jefferies 2022 London Healthcare Conference
Heiko Bruhn and Sébastien Stoitzner will be attending the Jefferies London Healthcare Conference from 15th-17th November 2022.
Read more “Jefferies 2022 London Healthcare Conference”GenSearch’s 10+2 anniversary
It was a great pleasure to celebrate GenSearch’s 10+2 anniversary. Watching the sunset on the Seine with a cool summer breeze with so many of you was just perfect!
Read more “GenSearch’s 10+2 anniversary”